haloperidol and 3,4-dicarboxyphenylglycine

haloperidol has been researched along with 3,4-dicarboxyphenylglycine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansari, MS; Baldwin, RM; Bubser, M; Conn, PJ; Johnson, KA; Jones, CK; Marvanova, M; Niswender, CM; Tantawy, MN	1

Other Studies

1 other study(ies) available for haloperidol and 3,4-dicarboxyphenylglycine

Article	Year
The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease. Neuropharmacology, 2013, Volume: 66 Topics: Aminobutyrates; Animals; Benzoates; Catalepsy; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Forelimb; Glycine; Haloperidol; Injections, Intraventricular; Male; Neostriatum; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Reserpine; Time Factors	2013

Article

Year

The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.

Neuropharmacology, 2013, Volume: 66

Topics: Aminobutyrates; Animals; Benzoates; Catalepsy; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Forelimb; Glycine; Haloperidol; Injections, Intraventricular; Male; Neostriatum; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Reserpine; Time Factors

2013